GLP-1 drugs for weight loss, like Saxenda and Wegovy , are FDA-approved for people with obesity (defined as a body mass index , or BMI, of 30 or higher ) or with a BMI of 27 or higher and a weight-related health condition, such as high cholesterol, type 2 diabetes, or high blood pressure
Providers will carefully formulate the medical weight management plan for each patient, making sure to set actionable steps and achievable goals
The Precision Peptide Genetic Test ($298) identifies your genetic predispositions across 14 metabolic pathways and 150+ peptide insights, including variants affecting GLP-1 receptor function and metabolic efficiency
A 2025 Stanford Medicine study identifying a naturally occurring peptide that suppressed appetite and reduced body weight without the nausea and muscle loss associated with semaglutide confirmed what many clinicians had already observed: the GLP-1 mechanism is powerful, but it carries side effects tied directly to how it works